Liminatus Pharma, Inc. Class A Common Stock (LIMN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Liminatus Pharma, Inc. Class A Common Stock
Address
12611 Hiddencreek Way
Cerritos, CA 90703
United States of America (the)
Phone
213 273 5453
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
May 01, 2025
Key Executives
| Name | Title | Pay | Year Born |
| Chris Kim | CEO, Chairman & President | 183,333 | 1960 |
| Scott Dam | Chief Financial Officer | 0 | 1979 |
| Byong Chul Yoo | Chief Science Officer & Member of Scientific Advisory Board | 0 | 1973 |
| Beom Kyu Choi | Chief Technology Officer & Member of Scientific Advisory Board | 0 | 1972 |
AD
Description
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
AD
